The Estonian National Hub (Estonian Paediatric Research Group – ELAV) was created by a cooperation agreement between the Tartu University Hospital, the Tallinn Children’s Hospital and the University of Tartu in 2018 and is part of the Clinical Research Center.
Paediatric Inflammatory Bowel Disease: : A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents Background and Aims: Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two ap[1]proved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [IBD]. There are…
Risk-proportionate approach to Paediatric Clinical Trials: The legal requirements, challenges, and the way forward under the European Union Clinical Trials Regulation has been published by Clinical Trials